Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The APA Just Pulled Outcomes Measurement Inside the Diagnosis
Short answer: On January 28, 2026, the American Psychiatric Association published a five-paper roadmap in the American Journal of Psychiatry proposing that functioning, quality of life, contextual factors, and biomarkers move inside the diagnostic frame itself. For behavioral health operators running multi-site models in Florida, Texas, and Arizona, that shift changes documentation workflows, utilization management, and payer contracting inside the next 18 months.
The papers are authored by members of the Future DSM Strategic Committee, a 17-member working group chaired by Maria Oquendo, MD, PhD, chair of psychiatry at the University of Pennsylvania Perelman School of Medicine. The APA Board of Trustees established the committee in May 2024, and four subcommittees now report into it, focused on social determinants of health, quality of life and functioning, biomarkers, and structure. The committee has even proposed to change the manual’s name so the “S” stands for Scientific rather than Statistical. As APA vice-chair Jonathan Alpert, MD, PhD, told Medscape at the release, “What we wanted to do was underscore that DSM is grounded in science first and foremost.”
Operators should read past the philosophy. The DSM sits underneath diagnosis, reimbursement, utilization management, quality reporting, and population health analytics. When the APA rewrites the architecture, SAMHSA, CMS, state Medicaid agencies, and commercial payers rewrite the downstream reporting they depend on.
From Symptom Checklists to Functional Outcomes
The four subcommittees mark a real departure from symptom thresholds and duration criteria as the primary diagnostic anchor. Payers are moving the same direction. CMS reports that as of January 2025, 53.4% of people with Traditional Medicare are in an accountable care relationship with a provider, representing more than 14.8 million people and marking a 4.3 percentage point increase from January 2024, the largest annual jump since CMS began tracking accountable care relationships. The stated destination is 100% of people with Traditional Medicare in an accountable care relationship by 2030.
The financial stakes on the provider side are real too. In performance year 2024, 75% of the 476 participating Shared Savings Program ACOs earned shared savings payments totaling $4.1 billion. Operators who treat PHQ-9 and GAD-7 as a clinical nicety are about to learn they were always a billing asset. Under Medicare, CPT 96127 (brief emotional/behavioral assessment) is billable up to 4 units per date of service at a small per-unit rate. Run that across a Level 2.5 partial hospitalization census (an outpatient level of care under the ASAM Criteria, 4th Edition) of 40 patients with twice-weekly assessments, and both the revenue line and the audit exposure compound quickly.
The harder problem is adoption. A peer-reviewed review in JAMA Psychiatry put a finer point on it: less than 20% of practitioners (17.9% of psychiatrists, 11.1% of psychologists, and 13.9% of masters-level practitioners) engage in MBC, and as little as 5% use it according to its empirically informed schedule (every session). Our AHS teams see this gap in nearly every operational assessment we run. The tools exist in the EMR. Clinical directors have not built the workflows that make scores reliable, time-stamped, and tied to level-of-care decisions.
Contextual Determinants and Where Audits Will Land Next
Another pillar of the roadmap is the formal integration of socioeconomic, cultural, and environmental determinants of mental health. A dedicated subcommittee is working on how those factors get measured, documented, and used to shape diagnosis across diverse contexts.
The volume problem is real. Among adults aged 18 or older in 2023, 22.8% (or 58.7 million people) had any mental illness in the past year, per SAMHSA’s 2023 NSDUH. And among the 48.5 million people aged 12 or older who had a SUD in 2023 and were therefore classified as needing substance use treatment, 15.6 percent (7.1 million people) received treatment and 85.4 percent (41.1 million people) did not receive substance use treatment.
Executive teams serving high-acuity, under-resourced populations cannot be benchmarked against operators serving low-acuity commercial census without contextual adjustment. The current DSM does not force that adjustment. The proposed framework does. CEOs in Florida, Tennessee, and Ohio should build data governance now. When clinicians capture social determinants as unstructured narrative in progress notes, those data points are not auditable, not reportable to a payer’s SIU on request, and not usable for risk adjustment.
Biomarkers, a Living Document, and Version Control You Do Not Yet Have
The roadmap also opens the door to biological markers and dimensional constructs. The committee wants to advance precision psychiatry by incorporating biomarkers, digital phenotyping, and other data into future editions of the DSM. A parallel subcommittee is working specifically on a continuously updated “truly living document” model.
Operators should read that carefully. An annually updated diagnostic framework introduces version control problems the current model never had. Today, a treatment center’s UR team works against DSM-5-TR (published 2022). Under a living-document model, the criteria a clinician documents against in Q1 may not be the criteria a payer audits against in Q4. CEOs face a contracting problem, a documentation training problem, and a denial-management problem all at once.
For organizations participating in risk-based contracts, executive teams must keep measurement systems stable enough to support longitudinal analysis. CEOs and clinical directors will need to decide which new data streams add operational value versus which add noise, cost, and compliance risk.
What CEOs Should Do in the Next 18 Months
Diagnosis and outcomes measurement begin to converge inside the same architecture. Behavioral health operators should be doing four things now:
- Audit the EMR. Confirm it can capture functional and quality-of-life data as structured fields, not narrative.
- Align documentation training. Tie it to both the ASAM Criteria, 4th Edition for level-of-care decisions and DSM-5-TR for diagnosis, while watching the APA’s continuous-update channel.
- Treat social determinants data as a regulated data category. Governance, retention, and access controls, not a clinical curiosity.
- Model measurement-based care unit economics at each level of care operators run, from Level 1 outpatient through Level 2.1 intensive outpatient, Level 2.5 partial hospitalization, residential levels, and residential withdrawal management.
Run the arithmetic on a single 40-bed Level 2.5 partial hospitalization program. Twice-weekly PHQ-9/GAD-7 administration billed under CPT 96127 produces meaningful ancillary revenue at a single site once you account for commercial-payer rate variance. Now add a second site. Now add a third.
CEOs who treat DSM modernization as a documentation problem will watch UR denials climb in 2027 and 2028. CEOs who treat it as operational redesign will own a defensible payer position when commercial contracts and CMS models start pricing outcomes directly. Our AHS teams work with executive teams on that redesign, and we would rather have the conversation eighteen months early than eighteen months late.
Frequently asked questions
When will the next DSM be released, and what should behavioral health operators do in the meantime?
The APA has not announced a firm publication date. On January 28, 2026, the Future DSM Strategic Committee published its roadmap as five papers in the American Journal of Psychiatry and proposed a continuous-update ‘living document’ model; per Medscape’s coverage of the release, there has been no decision yet on whether the new manual would even be numbered as DSM-6. DSM-5-TR (published 2022) remains the working manual. Operators should keep documentation aligned to DSM-5-TR today while building the governance and structured-field capture needed to absorb continuous updates.
How does DSM modernization affect payer audits and utilization management?
Functional status, quality of life, and contextual factors are being proposed as part of the diagnostic structure itself, not as external overlays. UM reviewers and SIU auditors will increasingly expect those data points to be structured and time-stamped in the chart. CMS reports that 53.4% of Traditional Medicare beneficiaries were in an accountable care relationship as of January 2025 (more than 14.8 million people), on the way to a 2030 goal of 100%, and commercial payers are tracking the same direction on measurement-based care.
How wide is the gap between what payers expect and what providers actually do on measurement-based care?
Wide. A peer-reviewed review in JAMA Psychiatry (Lewis et al., 2019) found only 17.9% of psychiatrists, 11.1% of psychologists, and 13.9% of masters-level practitioners engage in MBC, with as few as 5% using it every session. That gap is a documentation risk under current DSM-5-TR contracts and becomes a contracting risk under the future DSM model.
Does this affect ASAM level-of-care decisions for SUD treatment?
Indirectly, yes. DSM provides the diagnostic substrate; the ASAM Criteria, 4th Edition govern level-of-care placement across Level 1 outpatient, Level 2.1 intensive outpatient, Level 2.5 partial hospitalization (an outpatient level), residential levels, and residential withdrawal management. As DSM begins to incorporate functioning and contextual factors directly into diagnosis, the data feeding ASAM dimensional assessments will need to be cleaner, structured, and consistent across episodes of care.
References
- American Psychiatric Association: APA Releases Roadmap for the Future of the DSM (January 28, 2026)
- Oquendo MA et al., “Initial Strategy for the Future of DSM,” American Journal of Psychiatry (2026)
- Medscape: What Will the Next DSM Look Like?
- CMS Fact Sheet: CMS Moves Closer to Accountable Care Goals with 2025 ACO Initiatives
- CMS Press Release: CMS Proposes Transformational Medicare Reforms to Expand Accountable Care
- SAMHSA: Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 NSDUH
- Lewis CC et al., “Implementing Measurement-Based Care in Behavioral Health: A Review,” JAMA Psychiatry (2019)
- American Psychiatric Association: Resource Document on Implementation of Measurement-Based Care (2023)